Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR) [R41]
The summary for the Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR) [R41] Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | SAFE AND EFFECTIVE INSTRUMENTS AND DEVICES FOR USE IN THE NEONATAL INTENSIVE CARE UNITS (STTR) [R41] |
| Federal Agency Name: | National Institutes of Health |
| Program Name: | Blood Diseases and Resources Research |
| Grant Categories: | Health Income Security and Social Services |
| CFDA Number: | 93.839 |
| Funding Opportunity Number: | RFA-HD-12-193 |
| Posted Date: | Jun 14, 2011 |
| Creation Date: | Jun 14, 2011 |
| Original Application Deadline: | Sep 19, 2011 |
| Current Application Deadline: | Sep 19, 2011 |
| Archive Date: | Oct 20, 2011 |
| Total Program Funding: | Information not provided |
| Maximum Federal Grant Award: | $250,000 |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | Information not provided |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria: 1. Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; 2. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there can be no more than 49 percent participation by foreign business entities in the joint venture; 3. Is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, except in the case of a joint venture, where each entity to the venture must be 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States; and; 4. Has, including its affiliates, not more than 500 employees. SBCs must also meet the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns, other than investment companies licensed, or state development companies qualifying under the Small Business Investment Act of 1958, 15 U.S.C. 661, et seq., are affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Business concerns include, but are not limited to, any individual (sole proprietorship) partnership, corporation, joint venture, association, or cooperative. The SF424 (R and R) SBIR/STTR Application Guide should be referenced for detailed eligibility information.
- Grant Description
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung, and Blood Institute (NHLBI) invite Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to propose research to develop new devices and instruments, and/or improve existing devices and instruments, to monitor and treat newborn infants and small children safely and efficaciously.
- Link to Full Grant Announcement
-
http://grants.nih.gov/grants/guide/rfa-files/rfa-hd-12-193.html
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV] - Similar Government Grants
- • Erythropoiesis: Components and Mechanisms (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)
- • Excellence in Hemoglobinopathies Research Award (EHRA) (U54)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Clinical Hematology Research Career Development Program (K12)
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- More Grants from the National Institutes of Health
- • NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01)
- • Biophysical and Biomechanical Aspects of Embryonic Development (R01)
- • Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...
- • MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...
